These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 3190164)

  • 21. Cytokeratin expression patterns in low-grade papillary urothelial neoplasms of the urinary bladder.
    Ramos D; Navarro S; Villamón R; Gil-Salom M; Llombart-Bosch A
    Cancer; 2003 Apr; 97(8):1876-83. PubMed ID: 12673713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Changes in the mechanical integration of transitional epithelial cells and in the immune status of patients with bladder tumors].
    Bocharova OA; Serebriakova RV; Golubeva VA; Figurin KM; Bukharkin BV; Bodrova NB; Matveev BP; Baryshnikov AIu
    Urol Nefrol (Mosk); 1994; (3):27-30. PubMed ID: 8079407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasminogen- and colony-stimulating factor-1-associated markers in bladder carcinoma: diagnostic value of urokinase plasminogen activator receptor and plasminogen activator inhibitor type-2 using immunocytochemical analysis.
    Champelovier P; Boucard N; Levacher G; Simon A; Seigneurin D; Praloran V
    Urol Res; 2002 Oct; 30(5):301-9. PubMed ID: 12389118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. World/Health Organization/Internattional Society of Urologic Pathology.
    Alsheikh A; Mohamedali Z; Jones E; Masterson J; Gilks CB
    Mod Pathol; 2001 Apr; 14(4):267-72. PubMed ID: 11301341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impaired p63 expression associates with poor prognosis and uroplakin III expression in invasive urothelial carcinoma of the bladder.
    Koga F; Kawakami S; Fujii Y; Saito K; Ohtsuka Y; Iwai A; Ando N; Takizawa T; Kageyama Y; Kihara K
    Clin Cancer Res; 2003 Nov; 9(15):5501-7. PubMed ID: 14654529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Livin may serve as a marker for prognosis of bladder cancer relapse and a target of bladder cancer treatment.
    Liu HB; Kong CZ; Zeng Y; Liu XK; Bi JB; Jiang YJ; Han S
    Urol Oncol; 2009; 27(3):277-83. PubMed ID: 18555709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of matrix metalloproteinases 2 and 9 in bladder cancer.
    Papathoma AS; Petraki C; Grigorakis A; Papakonstantinou H; Karavana V; Stefanakis S; Sotsiou F; Pintzas A
    Anticancer Res; 2000; 20(3B):2009-13. PubMed ID: 10928143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 9p21 index as estimated by dual-color fluorescence in situ hybridization is useful to predict urothelial carcinoma recurrence in bladder washing cytology.
    Kawauchi S; Sakai H; Ikemoto K; Eguchi S; Nakao M; Takihara H; Shimabukuro T; Furuya T; Oga A; Matsuyama H; Takahashi M; Sasaki K
    Hum Pathol; 2009 Dec; 40(12):1783-9. PubMed ID: 19733894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved clonality analysis of multifocal bladder tumors by combination of histopathologic organ mapping, loss of heterozygosity, fluorescence in situ hybridization, and p53 analyses.
    Denzinger S; Mohren K; Knuechel R; Wild PJ; Burger M; Wieland WF; Hartmann A; Stoehr R
    Hum Pathol; 2006 Feb; 37(2):143-51. PubMed ID: 16426913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clonal origin of lymph node metastases in bladder carcinoma.
    Jones TD; Carr MD; Eble JN; Wang M; Lopez-Beltran A; Cheng L
    Cancer; 2005 Nov; 104(9):1901-10. PubMed ID: 16196038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Uroplakin III, a specific membrane protein of urothelial umbrella cells, as a histological markers for metastatic transitional cell carcinomas].
    Moll R; Laufer J; Wu XR; Sun TT
    Verh Dtsch Ges Pathol; 1993; 77():260-5. PubMed ID: 7511294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Soft tissue tumors of the urinary bladder, Part I: myofibroblastic proliferations, benign neoplasms, and tumors of uncertain malignant potential.
    Lott S; Lopez-Beltran A; Maclennan GT; Montironi R; Cheng L
    Hum Pathol; 2007 Jun; 38(6):807-23. PubMed ID: 17509394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
    Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
    Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utility of diagnostic and prognostic markers in urothelial carcinoma of the bladder.
    Coleman JF; Hansel DE
    Adv Anat Pathol; 2009 Mar; 16(2):67-78. PubMed ID: 19550368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA-aneuploidy as marker for neoplasia in G1-urothelial carcinomas.
    Planz B; Striepecke E; Wolff JM; Effert P; Jakse G; Böcking A
    Gen Diagn Pathol; 1996 Oct; 142(2):69-73. PubMed ID: 8950570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Study of the DNA content of 72 cases of bladder tumors using flow cytometry. Relation with anatomoclinical data].
    Devonec M; Hijazi A; Muchada E; Bouvier R; Dubernard JM
    J Urol (Paris); 1986; 92(4):223-30. PubMed ID: 3782829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Value of multicolour fluorescence in situ hybridisation (UroVysion) in the differential diagnosis of flat urothelial lesions.
    Schwarz S; Rechenmacher M; Filbeck T; Knuechel R; Blaszyk H; Hartmann A; Brockhoff G
    J Clin Pathol; 2008 Mar; 61(3):272-7. PubMed ID: 17693577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proceedings: Membrane potentials and properties of human erythrocytes and ghosts assessed with a fluorescent dye, 3,3'-dipropyl-2,2' thiadicarbocyanine, diS-C3-(5).
    Hladky SB; Rink TJ
    J Physiol; 1976 Jun; 258(2):100P-101P. PubMed ID: 957139
    [No Abstract]   [Full Text] [Related]  

  • 39. Simultaneous staining of nuclear DNA and blood group cell surface antigens on cells from bladder irrigation fluid.
    Devonec M; Fontaniere B; Blanc-Brunat N; Muchada E; Dubernard JM
    Anal Quant Cytol Histol; 1985 Mar; 7(1):69-71. PubMed ID: 4003967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of membrane potential probes.
    Waggoner AS
    Soc Gen Physiol Ser; 1988; 43():209-15. PubMed ID: 3077547
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.